Evidence map›Paper›PMID 38491488›Full record

ArticleTrials2024

Correction: Detailed statistical analysis plan for ALBINO: effect of Allopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).

Corinna Engel, Mario Rüdiger, Manon J N L Benders, Frank van Bel, Karel Allegaert, Gunnar Naulaers, Dirk Bassler, Katrin Klebermaß-Schrehof, Maximo Vento, Ana Vilan and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Trials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Corinna EngelCenter for Pediatric Clinical Studies (CPCS), University Hospital Tuebingen, Tuebingen, Germany. Corinna.Engel@med.uni-tuebingen.de.
Mario RüdigerUniversitätsklinikum C. G. Carus - Medizinische Fakultät der TU Dresden, Dresden, Germany.
Manon J N L BendersUniversitair Medisch Centrum Utrecht, Utrecht, The Netherlands.
Frank van BelUniversitair Medisch Centrum Utrecht, Utrecht, The Netherlands.
Karel AllegaertUniversity Hospitals Leuven, Leuven, Belgium.
Gunnar NaulaersUniversity Hospitals Leuven, Leuven, Belgium.
Dirk BasslerUniversitaetsSpital Zuerich, Zuerich, Switzerland.
Katrin Klebermaß-SchrehofMedizinische Universitaet Wien, Wien, Austria.
Maximo VentoHospital Universitario y Politécnico La Fe, Valencia, Spain.
Ana VilanCentro Hospitalar Universitário São João Porto, Porto, Portugal.
Mari FalckOslo Uni- versitetssykehus HF, Oslo, Norway.
Isabella MauroAzienda sanitaria universitaria integrata di Udine, Udine, Italy.
Marjo MetsärantaHelsinki University Hospital (HUS), Helsinki, Finland.
Sampsa VanhataloHelsinki University Hospital (HUS), Helsinki, Finland.
Jan MazelaDepartment of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
Tuuli MetsvahtTartu University Hospital, Tartu, Estonia.
Roselinda van der VlughtACE Pharmaceuticals BV, Zeewolde, The Netherlands.
Axel R FranzCenter for Pediatric Clinical Studies (CPCS), University Hospital Tuebingen, Tuebingen, Germany.
ALBINO Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38491488
PMCPMC10941458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.